Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Acta Bio-Medica : Atenei Parmensis|May 12, 2022
The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A NetworkVincenzo De Sanctis, Ashraf Soliman, Ploutarchos Tzoulis, et al.Blood Cells, Molecules & Diseases|May 1, 2013
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia majorAldo Filosa, Angela Vitrano, Paolo Rigano, et al.Magnetic Resonance in Medicine|December 1, 2011
Feasibility, reproducibility, and reliability for the T*2 iron evaluation at 3 T in comparison with 1.5 TAntonella Meloni, Vincenzo Positano, Petra Keilberg, et al.Blood Transfusion = Trasfusione Del Sangue|October 1, 2020
Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in thalassemia major: a large, multicentre studyLaura Pistoia, Antonella Meloni, Paolo Ricchi, et al.Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 18, 2013
Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapyAlessia Pepe, Antonella Meloni, Giuseppe Rossi, et al.British Journal of Haematology|October 18, 2016
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?Angela Vitrano, Giuseppina Calvaruso, Eliana Lai, et al.British Journal of Haematology|October 12, 2013
Cardiac complications and diabetes in thalassaemia major: a large historical multicentre studyAlessia Pepe, Antonella Meloni, Giuseppe Rossi, et al.American Journal of Hematology|May 25, 2012
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patientsAurelio Maggio, Angela Vitrano, Gaetano Lucania, et al.American Journal of Hematology|August 1, 2015
Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patientsPaolo Ricchi, Antonella Meloni, Anna Spasiano, et al.Mediterranean Journal of Hematology and Infectious Diseases|November 20, 2014
Insulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia MajorVincenzo De Sanctis, Ashraf T Soliman, Giancarlo Candini, et al.Pageof 4